l carnitine vial L-Carnitine 500mg/mL (10mL) – Research-Grade Compound 10 Ml L Carnitine Injection

Proven Results : Clinical testing showed visible improvements +135.02% skin elasticity, +111.73% deep hydration, and +150.69% radiance after overnight use

BMJ Open 2 , e000412 (2012)

Tesamorelin vs CJC-1295/Ipamorelin at a Glance Tesamorelin FDA Status FDA-approved (Egrifta, November 2010) CJC-1295/Ipam FDA Status Compounded (CJC-1295 reached Phase 2) Tesamorelin Mechanism GHRH receptor only (DPP-IV protected) CJC-1295/Ipam Mechanism GHRH + ghrelin receptor (dual pathway) Strongest Evidence Tesamorelin: 2 Phase 3 RCTs, 816 patients, CT-measured fat Most Popular CJC-1295/Ipamorelin (dual pathway, broader benefits) The Core Difference Tesamorelin and CJC-1295 both bind the GHRH receptor on pituitary somatotroph cells to stimulate growth hormone release

NCCIH notes that research does not support alpha-lipoic acid for blood-glucose control, and evidence for neuropathy-related outcomes is mixed

Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice [J]